HUMAN LEUKOCYTE ANTIGEN-B27 AND
DISEASE SUSCEPTIBILITY IN VOJVODINA, SERBIA
Vojvodić S1,*, Ademović-Sazdanić D1, Busarčević I2
*Corresponding Author: Assistant Professor Svetlana Vojvodić, M.D., Ph.D., Department for Laboratory
Testing, Tissue Typing Compartment, Institute for Blood Transfusion of Vojvodina, Hajduk Veljkova 9a,
21000 Novi Sad, Serbia; Tel.: +381-21-4877-963; Mobile: +381-64-861-58-12; Fax: +381-21-4877-978;
E-mail: ssvu@EUnet.rs
page: 55
|
|
REFERENCES
1. Hulsmeyer M, Hillig RC, Volz A, Ruhl M,
Schroder W, Saengen W, et al. HLA-B27 Subtypes
differentially associated with disease exhibit
subtle structural alterations. J Biol Chem.
2002; 227(49): 47844-47853.
2. Popa OM, Bojinica M, Bojinica V, Ciofu C, Dutescu
MI, Bardan A, et al.Distribution of HLAB27
in Romanian spondyloarthritides patients.
Int J Immunogenet. 2010; 37(6): 513-516.
3. Colbert RA, DeLay ML, Layh-Schmitt G, Sowders
DP. HLA-B27 misfolding and spondyloarthropathies.
Prion. 2009; 3(1): 15-26.
4. Bowness P. HLA B27 in health and disease:
a double-edged sword? Rheumatology. 2002;
41(8): 857-868.
5. Huhtinen M. Acute anterior uveitis and HLAB27:
infectious background, systemic inflamation
and prognosis of the patients. Academic
dissertation, defended at the Medical Faculty
of the University of Helsinki, Helsinki, 2002.
6. Allen RL, Bowness P, McMichael AJ. The role
of HLA-B27 in spondyloarthritis. Immunogenetics.
1999; 50(3-4): 220-227.
7. Marsh SGE. Nomenclature for factors of the
HLA system, update September 2011. Int J Immunogenet.
2011; 39(1): 95-97.
8. Khan MA. Recent advances in the genetics of
ankylosing spondylitis. Future Rheumatol. 2008;
3(5): 403-405.
9. Cauli A, Dessole G, Fiorillo MT, Vacca A, Mameli
A, Bitti P, et al. Increased level of HLA B27 expression in ankylosing spondylitis patients
compared with healthy HLA-B27-positive
subjects: a possible further susceptibility factor
for the development of disease. Rheumatology.
2002; 41(12): 1375-1379.
10. Vartdal F, Gaudernack G, Funderud S, Bratlie
A, Lea T, Ugelstad J, et al. HLA class I and II
typing using cells positively selected from blood
by immunomagnetic isolation-a fast and reliable
technique. Tissue Antigens. 1986; 25(5): 301-312.
11. Vartdal F, Bratlie A, Gaudernack G, Funderud S,
Lea T, Thorsby E. Microcytotoxic HLA typing
of cells directly isolated from blood by means
of antibody-coated microspheres. Transplant
Proceedings. 1987; 19(1): 655-657.
12. Walker RH. Technical Manual, 11th ed. Bethesda:
American Association of Blood Banks, 1993:
305-307.
13. Stites DP, Stobo JD, Wells JV. Osnovna i klinička
imunologija. Beograd: Savremena Administracija,
1989; 50-63.
14. Svejgaard A, Platz R, Ryder LP. HLA and disease
1982-A survey. Immunolog Rev. 1983;
70(1): 193-201.
15. Bengston BO, Thompson G. Measuring the
strength of associations between HLA antigens and
disease. Tissue Antigens. 1981; 18(5): 356-363.
16. Green A. The epidemiologic approach to studies
of association between HLA and disease.II Estimation
of absolute risk, etiologic and preventive
fraction. Tissue Antigens. 1982; 19(4): 259-168.
17. Petz B. Osnovne statističke metode. Zagreb:
Izdanja škole narodnog zdravlja “Andrija Štampar.”
1967: 111-134.
18. Snedecor GW, Cochan GW. Statistical Methods.
Ames: The Iowa State University Press. 1956:
219-221.
19. Emam SJ, Badri S, Bayat A, Dashtebozorg N, Khosravi
A. Evaluation of 278 HLA-B27 positive patients
suspected of seronegative spondyloarthropathies.
Pakistan J Med Sci. 2007; 23(5): 728-732.
20. McMichael A, Bowness P. HLA-B27:natural
function and pathogenic role in spondyloarthritis.
Arthritis Res. 2002; 4(Suppl 3): S153-S158.
21. Sahin S, Aydogan L, Benli I, Ozyurt H. Distribution
of HLA-B27 and CYP2D6*4 mutations
in the middle Black Sea area (Tokat) of Turkey.
Genet Molec Res. 2011; 10(4): 3987-3991.
22. Sheehan NJ. The ramifications of HLA-B27. J
Roy Soc Med. 2004; 97(1): 10-14.
23. Dhurandhar PS, Shankarkumar U. HLA Association
in seronegative spondyloarthritis patients
from Mumbai, India. Int J Hum Genet. 2007;
7(3): 235-239.
24. Pitchappan RM, Balakrlshnan K, Mahendran V,
Brahmajathi V. HLA and disease susceptibility
in Tamil Nadu, S. India. Indian J Hum Genet.
1995; 1(1):56-62.
25. Kim T-H, Uhm W-S, Inman RD. Pathogenesis
of ankylosing spondylitis and reactive arthritis.
Curr Opin Rheumatol. 2005; 17(4): 400-405.
26. Colmegna I, Cuchacovich R, Espinoza LR.
HLA- B27 associated reactive arthritis: pathogenetic
and clinical considerations. Clin Microbiol
Rev. 2004; 17(2): 348-369.
27. Carter JD, Hudson AP. Reactive arthritis: clinical
aspects and medical management. Rheumatic
Dis Clin North Am. 2009; 35(1): 21-44.
28. FitzGerald O, Winchester R. Psoriatic arthritis:
from pathogenesis to therapy. Arthritis Res Ther.
2009; 11(1): 214-223.
29. Khairallah M,Yahia SB, Ladjimi A, Messaoud
R, Zaouali S, Attia S, et al. Pattern of uveitis in
a referral centre in Tunisia, North Africa. Eye.
2007; 21(1): 33-39.
30. Chang JH, McCluskey PJ, Wakefield D. Acute
anterior uveitis and HLA-B27: what’s new? In:
Pleyer U, Forrester JV, Eds. Uveitis and Immunological
Disorders. Heidelberg: Springer-
Verlag. 2009:9-17.
31. Chang JH, McCluskey PJ, Wakefield D. Acute
anterior uveitis and HLA-B27. Survey Ophtalmol.
2005; 50(4): 364-388.
32. Mishra MN, Bharucha KM. HLA-B27 Association
with uveitis in an Asian Indian population.
Iranian J Immunol. 2011; 8(2): 85-89.
|
|
|
|
 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
|
